Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from Zhong Ji Longevity Science Group Limited ( (HK:0767) ).
Zhong Ji Longevity Science Group Limited has announced a delay in sending to shareholders a circular relating to its proposed major and connected transaction to acquire 25% of the issued share capital of Asian Integrated Cell Laboratory Limited, which will involve the issuance of convertible notes under a specific mandate. The circular, originally expected to be dispatched on or before 22 December 2025, will now be sent on or before 16 January 2026 to allow more time to prepare and finalise required information, potentially extending the timetable for shareholder approval and completion of the acquisition but not altering the substance of the proposed deal.
The most recent analyst rating on (HK:0767) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Zhong Ji Longevity Science Group Limited stock, see the HK:0767 Stock Forecast page.
More about Zhong Ji Longevity Science Group Limited
Zhong Ji Longevity Science Group Limited is a Bermuda-incorporated company listed in Hong Kong, engaged in longevity and life-science related businesses, with a focus on advanced biomedical and cell-related technologies through strategic investments and acquisitions in the region.
Average Trading Volume: 564,249
Technical Sentiment Signal: Hold
Current Market Cap: HK$324.7M
Find detailed analytics on 0767 stock on TipRanks’ Stock Analysis page.